Literature DB >> 21825314

C-kit expression in canine mucosal melanomas.

S J Newman1, J M Jankovsky, B W Rohrbach, A K LeBlanc.   

Abstract

The c-kit receptor is responsible for transmission of promigration signals to melanocytes; its downregulation may be involved in malignant progression of human melanocytic neoplasms. Expression of this receptor has not been examined in normal or neoplastic melanocytes from dogs. In this study, 14 benign dermal and 61 malignant mucosal melanocytic tumors were examined for c-kit (KIT) expression. Sites of the mucosal melanomas were gingiva (not further specified; n = 30), buccal gingiva (n = 6), soft palate (n = 4), hard palate (n = 5), tongue (n = 7), lip (n = 6), and conjunctiva (n = 3). Melan A was expressed in all 14 dermal melanocytomas and in 59 of 61 (96.7%) tumors from oral or conjunctival mucosa, confirming melanocytic origin. C-kit receptor expression was strong and diffuse throughout the cytoplasm in all 14 dermal melanocytomas and was identified in basilar mucosal melanocytes over submucosal neoplasms (27 of 61, 44.3%), junctional (neoplastic) melanocytes (17 of 61, 27.9%), and, less commonly, neoplastic melanocytes of the subepithelial tumors (6 of 61, 9.8%). KIT expression anywhere within the resected melanomas correlated with significantly longer survival. These results suggest that c-kit receptor expression may be altered in canine melanomas and may have potential as a prognostic indicator for mucosal melanomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825314     DOI: 10.1177/0300985811414032

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  10 in total

1.  Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization.

Authors:  Kelsey Poorman; Luke Borst; Scott Moroff; Siddharth Roy; Philippe Labelle; Alison Motsinger-Reif; Matthew Breen
Journal:  Chromosome Res       Date:  2014-12-16       Impact factor: 5.239

2.  Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.

Authors:  R Mark Simpson; Boris C Bastian; Helen T Michael; Joshua D Webster; Manju L Prasad; Catherine M Conway; Victor M Prieto; Joy M Gary; Michael H Goldschmidt; D Glen Esplin; Rebecca C Smedley; Adriano Piris; Donald J Meuten; Matti Kiupel; Chyi-Chia R Lee; Jerrold M Ward; Jennifer E Dwyer; Barbara J Davis; Miriam R Anver; Alfredo A Molinolo; Shelley B Hoover; Jaime Rodriguez-Canales; Stephen M Hewitt
Journal:  Pigment Cell Melanoma Res       Date:  2013-11-21       Impact factor: 4.693

Review 3.  Molecular targets for anticancer therapies in companion animals and humans: what can we learn from each other?

Authors:  Irati Beltrán Hernández; Jannes Z Kromhout; Erik Teske; Wim E Hennink; Sebastiaan A van Nimwegen; Sabrina Oliveira
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

4.  KIT Somatic Mutations and Immunohistochemical Expression in Canine Oral Melanoma.

Authors:  Ginevra Brocca; Beatrice Poncina; Alessandro Sammarco; Laura Cavicchioli; Massimo Castagnaro
Journal:  Animals (Basel)       Date:  2020-12-10       Impact factor: 2.752

5.  Molecular Genetic Investigation of Digital Melanoma in Dogs.

Authors:  David Conrad; Alexandra Kehl; Christoph Beitzinger; Thomas Metzler; Katja Steiger; Nicole Pfarr; Konrad Fischer; Robert Klopfleisch; Heike Aupperle-Lellbach
Journal:  Vet Sci       Date:  2022-01-30

6.  Multimodal Treatment of a Canine Lingual Melanoma Using a Combination of Immunotherapy and a Tyrosine Kinase Inhibitors.

Authors:  Alexander Berry; Alison Hayes; Luca Schiavo; Jane Dobson
Journal:  Vet Sci       Date:  2022-01-29

7.  Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.

Authors:  Sanna Hämäläinen; Lauri Kareinen; Antti Sukura; Ilona Kareinen
Journal:  Vet Pathol       Date:  2021-12-12       Impact factor: 2.221

8.  Stem cell growth factor receptor in canine vs. feline osteosarcomas.

Authors:  Birgitt Wolfesberger; Andrea Fuchs-Baumgartinger; Juraj Hlavaty; Florian R Meyer; Martin Hofer; Ralf Steinborn; Christiane Gebhard; Ingrid Walter
Journal:  Oncol Lett       Date:  2016-08-12       Impact factor: 2.967

9.  Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.

Authors:  Bih-Rong Wei; Helen T Michael; Charles H C Halsey; Cody J Peer; Amit Adhikari; Jennifer E Dwyer; Shelley B Hoover; Rajaa El Meskini; Serguei Kozlov; Zoe Weaver Ohler; William D Figg; Glenn Merlino; R Mark Simpson
Journal:  Pigment Cell Melanoma Res       Date:  2016-09-22       Impact factor: 4.693

Review 10.  Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.

Authors:  Belen Hernandez; Hibret A Adissu; Bih-Rong Wei; Helen T Michael; Glenn Merlino; R Mark Simpson
Journal:  Int J Mol Sci       Date:  2018-01-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.